Literature DB >> 18048070

An in-host model of acute infection: measles as a case study.

J M Heffernan1, M J Keeling.   

Abstract

The epidemiology of acute infections is strongly influenced by the immune status of individuals. In-host models can provide quantitative predictions of immune status and can thus offer valuable insights into the factors that influence transmission between individuals and the effectiveness of vaccination protocols with respect to individual immunity. Here we develop an in-host model of measles infection. The model explicitly considers the effects of immune system memory and CD8 T-cells, which are key to measles clearance. The model is used to determine the effects of waning immunity through vaccination and infection, the effects of booster exposures or vaccines on the level of immunity, and the immune system characteristics that result in measles transmission (R(0)>1) even if an individual has no apparent clinical symptoms. We find that the level of immune system CD8 T-cells at the time of exposure to measles determines whether an individual will experience a measles infection or simply a boost in immunity. We also find that the infected cell dynamics are a good indicator of measles transmission and the degree of symptoms that will be experienced. Our results indicate that the degree of immunity in adults is independent of the source of exposure in early childhood, be it vaccine or natural infection.

Entities:  

Mesh:

Year:  2007        PMID: 18048070     DOI: 10.1016/j.tpb.2007.10.003

Source DB:  PubMed          Journal:  Theor Popul Biol        ISSN: 0040-5809            Impact factor:   1.570


  13 in total

1.  Implications of vaccination and waning immunity.

Authors:  J M Heffernan; M J Keeling
Journal:  Proc Biol Sci       Date:  2009-03-04       Impact factor: 5.349

2.  Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics.

Authors:  Wen-Hsuan W Lin; Roger D Kouyos; Robert J Adams; Bryan T Grenfell; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-07       Impact factor: 11.205

3.  Immuno-epidemiology of a population structured by immune status: a mathematical study of waning immunity and immune system boosting.

Authors:  M V Barbarossa; G Röst
Journal:  J Math Biol       Date:  2015-04-02       Impact factor: 2.259

Review 4.  Viral kinetic modeling: state of the art.

Authors:  Laetitia Canini; Alan S Perelson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-06-25       Impact factor: 2.745

5.  Influenza pandemic waves under various mitigation strategies with 2009 H1N1 as a case study.

Authors:  Suma Ghosh; Jane Heffernan
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

6.  A large-scale immuno-epidemiological simulation of influenza A epidemics.

Authors:  Sarah Lukens; Jay DePasse; Roni Rosenfeld; Elodie Ghedin; Ericka Mochan; Shawn T Brown; John Grefenstette; Donald S Burke; David Swigon; Gilles Clermont
Journal:  BMC Public Health       Date:  2014-09-29       Impact factor: 3.295

7.  On the Role of CD8+ T Cells in Determining Recovery Time from Influenza Virus Infection.

Authors:  Pengxing Cao; Zhongfang Wang; Ada W C Yan; Jodie McVernon; Jianqing Xu; Jane M Heffernan; Katherine Kedzierska; James M McCaw
Journal:  Front Immunol       Date:  2016-12-20       Impact factor: 7.561

8.  Immunobiological outcomes of repeated chlamydial infection from two models of within-host population dynamics.

Authors:  David M Vickers; Qian Zhang; Nathaniel D Osgood
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

9.  Immune amnesia induced by measles and its effects on concurrent epidemics.

Authors:  Guillermo B Morales; Miguel A Muñoz
Journal:  J R Soc Interface       Date:  2021-06-16       Impact factor: 4.118

10.  Within-host viral dynamics of dengue serotype 1 infection.

Authors:  Hannah E Clapham; Vianney Tricou; Nguyen Van Vinh Chau; Cameron P Simmons; Neil M Ferguson
Journal:  J R Soc Interface       Date:  2014-07-06       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.